Árpád Szomor

950 total citations
31 papers, 267 citations indexed

About

Árpád Szomor is a scholar working on Pathology and Forensic Medicine, Oncology and Genetics. According to data from OpenAlex, Árpád Szomor has authored 31 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 12 papers in Oncology and 9 papers in Genetics. Recurrent topics in Árpád Szomor's work include Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Glycosylation and Glycoproteins Research (4 papers). Árpád Szomor is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Glycosylation and Glycoproteins Research (4 papers). Árpád Szomor collaborates with scholars based in Hungary, Germany and Italy. Árpád Szomor's co-authors include B Speck, Till Hoffmann, Jakob Passweg, André Tichelli, Aloïs Gratwohl, László Pajor, Robert Pytlík, Gergely Kriván, Hermann Einsele and Hans Erik Johnsen and has published in prestigious journals such as Blood, Annals of Oncology and British Journal of Haematology.

In The Last Decade

Árpád Szomor

29 papers receiving 263 citations

Peers

Countries citing papers authored by Árpád Szomor

Since Specialization

Citations

This map shows the geographic impact of Árpád Szomor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Árpád Szomor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Árpád Szomor more than expected).

Fields of papers citing papers by Árpád Szomor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Árpád Szomor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Árpád Szomor. The network helps show where Árpád Szomor may publish in the future.

Co-authorship network of co-authors of Árpád Szomor

This figure shows the co-authorship network connecting the top 25 collaborators of Árpád Szomor. A scholar is included among the top collaborators of Árpád Szomor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Árpád Szomor. Árpád Szomor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Use of blood products during the first months of COVID-19 pandemic period: A single center report 2023 ·Heliyon ·(unknown), (unknown), Hussain Alizadeh, Árpád Szomor, András Vereczkei, T. Kiss, Attila Miseta, Margit Solymár, (unknown)	2
2	Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era — real-world data from Hungary 2023 ·Annals of Hematology ·(unknown), (unknown), László Imre Pinczés, (unknown), (unknown), Árpád Szomor, (unknown), László Gopcsa, Árpád Illés, Zsófia Miltényi	2
3	Absence of Nkx2-3 induces ectopic lymphatic endothelial differentiation associated with impaired extramedullary stress hematopoiesis in the spleen 2023 ·Frontiers in Cell and Developmental Biology ·(unknown), (unknown), (unknown), Árpád Szomor, Gergely Berta, Zoltán Jakus, Zoltán Kellermayer, Péter Balogh	1
4	Two-Year Event-Free Survival Prediction in DLBCL Patients Based on In Vivo Radiomics and Clinical Parameters 2022 ·Frontiers in Oncology ·(unknown), László Papp, (unknown), Zoltán Tóth, (unknown), Dániel Sándor Veres, Domokos Máthé, Ferenc Budán, (unknown), (unknown), László Pajor, Árpád Szomor, (unknown), Hussain Alizadeh	17
5	826O Copanlisib plus rituximab vs placebo plus rituximab in patients (pts) with relapsed marginal zone lymphoma (MZL) treated in the phase III CHRONOS-3 trial 2021 ·Annals of Oncology ·(unknown), James Jin, Árpád Szomor, (unknown), (unknown), (unknown), (unknown), (unknown), Florian Hiemeyer, Barrett H. Childs, Matthew J. Matasar, Pier Luigi Zinzani	2
6	Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma 2020 ·Annals of Hematology ·László Imre Pinczés, (unknown), Árpád Illés, (unknown), Klára Piukovics, Árpád Szomor, László Gopcsa, Zsófia Miltényi	12
7	Real World Efficacy and Safety Results of Ixazomib Lenalidomide and Dexamethasone Combination in Relapsed/Refractory Multiple Myeloma: Data Collected from the Hungarian Ixazomib Named Patient Program 2019 ·Pathology & Oncology Research ·Gergely Varga, Zsolt Nagy, Judit Demeter, (unknown), Árpád Szomor, Hussain Alizadeh, (unknown), (unknown), Márk Plander, (unknown), László Váróczy, Árpád Illés, Árpád Bátai, (unknown), Gábor Mikala	17
8	Nasalis típusú extranodalis natural killer T-sejtes lymphoma hazai előfordulása és kezelésével szerzett tapasztalatok 2017 ·Orvosi Hetilap ·(unknown), Árpád Szomor, (unknown), Zsófia Miltényi, (unknown), Zita Borbényi, (unknown), László Krenács, Enikő Bagdi, Klára Piukovics	1
9	In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden 2012 ·Bone Marrow Transplantation ·Nicole Blijlevens, (unknown), Gergely Kriván, Werner Rabitsch, Árpád Szomor, Robert Pytlík, (unknown), Hans Erik Johnsen, T. de Witte, Hermann Einsele, Tapani Ruutu, Dietger Niederwieser, (unknown)	36
10	Randomized Controlled Trial of Two Different Dosing Regimens of Palifermin to Prevent Mucositis In Multiple Myeloma Patients Receiving One-Day Administration of High-Dose Melphalan 2010 ·Blood ·Nicole M. A. Blijlevens, (unknown), Gergely Kriván, Werner Rabitsch, Árpád Szomor, Robert Pytlík, (unknown), Hans Erik Johnsen, Tapani Ruutu, Hermann Einsele, Dietger Niederwieser	9
11	Multidrug resistance in chronic lymphocytic leukemia 2008 ·Orvosi Hetilap ·(unknown), Tamás Magyarlaki, Gábor Kovács, Ãgnes Nagy, Árpád Szomor, (unknown), (unknown), Margit Tökés‐Füzesi, Orsolya Rideg, László Pótó, László Pajor, Béla Kajtár, Hajna Losonczy	3
12	A Cumulative Series from 14 Western Countries Suggests That Rituximab Significantly Changed the Dismal Natural History of Intravascular Large B-Cell Lymphoma (IVL) . 2008 ·Blood ·Andrés JM Ferreri, Silvia Govi, Giuseppina Dognini, Maria Bouzani, (unknown), M. D’Incan, Éric Delaporte, Mehdi Hamadani, Fabrice Jardin, Magdalena Martusewicz-Boros, Mauro Montanari, Árpád Szomor, Roberto Crocchiolo, Emanuele Zucca, Franco Cavalli, Maurilio Ponzoni	1
13	The addition of rituximab to anthracycline‐based chemotherapy significantly improves outcome in ‘Western’ patients with intravascular large B‐cell lymphoma 2008 ·British Journal of Haematology ·Andrés J.M. Ferreri, Giuseppina Dognini, Osnat Bairey, Árpád Szomor, Carlos Montalbán, Barbara Horváth, Judit Demeter, Lilj Uziel, Riccardo Soffietti, John F. Seymour, Achille Ambrosetti, Rein Willemze, Maurizio Martelli, Giuseppe Rossi, Anna Candoni, Amalia De Renzo, Claudio Doglioni, Emanuele Zucca, Franco Cavalli, Maurilio Ponzoni, (unknown)	69
14	Primary bone marrow T-cell anaplastic large cell lymphoma with triple m gradient 2007 ·Pathology & Oncology Research ·Árpád Szomor, Talal Al Saati, Georges Delsol, László Kereskai, (unknown), Hajna Losonczy	3
15	Prevalence and Clinical Significance of Single and Combined Inherited Thrombophilias. 2005 ·Blood ·Hajna Losonczy, Ãgnes Nagy, Orsolya Tóth, (unknown), Marianna Dávid, (unknown), (unknown), Árpád Szomor	0
16	Genotypic analysis in primary systemic anaplastic large cell lymphoma 2003 ·Pathology & Oncology Research ·Árpád Szomor, (unknown), (unknown), Talal Al Saati, (unknown), László Pajor, G Kelényi, Georges Delsol, Hajna Losonczy	2
17	The existence of lymphoid lineage restricted Philadelphia chromosome-positive acute lymphoblastic leukemia with heterogeneous bcr-abl rearrangement 2000 ·Leukemia ·László Pajor, (unknown), László Kereskai, P. Kajtár, Árpád Szomor, Miklós Egyed, J Ivánýi, (unknown)	12
18	Myeloid leukemia and myelodysplastic syndrome relapsing as granulocytic sarcoma (chloroma) after allogeneic bone marrow transplantation 1997 ·Annals of Hematology ·Árpád Szomor, Jakob Passweg, André Tichelli, Till Hoffmann, B Speck, Aloïs Gratwohl	41
19	Changes in adhesion molecule expression and function in B‐cell chronic lymphocytic leukaemia after in vitro interferon‐α stimulation 1995 ·European Journal Of Haematology ·(unknown), (unknown), Imre Ocsovszki, János Milosevits, Árpád Szomor, (unknown)	3
20	Expression and function of L-selectin molecules (LECAM-1) in B-cell chronic lymphocytic leukemia. 1994 ·PubMed ·(unknown), (unknown), János Milosevits, Imre Ocsovszki, Árpád Szomor, (unknown)	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact